TLRY Stock Back Into The Limelight – A Look At The Key Developments That Sparked Investor Optimism
Tilray stock was in focus after a recent government effort to reclassify Hemp and the upcoming DEA hearing about marijuana.
Stocktwits
More News
The Short Seller Who Took On GameStop Just Got Convicted Of Fraud – And Says ‘This Is Not Over’
Prosecutors said Andrew Left profited from misleading stock calls.
Stocktwits
Cronos Group Q1 Earnings Call Highlights
Cronos Group Q1 Earnings Call Highlights...
Yahoo! Finance: News
Cronos Group (CRON) Q1 Earnings Meet Estimates
Cronos (CRON) delivered earnings and revenue surprises of 0.00% and +6.94%, respectively, for the quarter ended March 2026. Do the numbers hold clues to what lies ahead for the stock?
Zacks
Cronos Group Inc Q1 Profit Advances
(RTTNews) - Cronos Group Inc (CRON) released earnings for its first quarter that Increased, from last year...
Nasdaq News: Markets
Cronos Group (CRON) Expected to Announce Quarterly Earnings on Monday
Cronos Group (NASDAQ:CRON) will be releasing its Q1 2026 earnings before the market opens on Monday, May 11. (View Earnings Report at...
MarketBeat
Traders Buy High Volume of Cronos Group Call Options (NASDAQ:CRON)
Cronos Group Inc. (NASDAQ:CRON - Get Free Report) was the recipient of unusually large options trading on Thursday. Stock investors bought 5,040 call options on the stock. This is an increase of...
MarketBeat
Cronos Group (TSE:CRON) Trading Down 1.6% - Here's What Happened
Cronos Group (TSE:CRON) Stock Price Down 1.6% - Should You Sell...
MarketBeat
Tilray Stock Eyes Breakout Week: Trump’s Cannabis Order Opens Door To US Cancer Market Entry
Trump has also called on Congress to preserve access to full-spectrum CBD products and expand research.
Stocktwits
Cronos Group (NASDAQ:CRON) Shares Gap Up - Time to Buy?
Cronos Group (NASDAQ:CRON) Shares Gap Up - Should You Buy...